Emergent BioSolutions Inc. EBS announced that it completed the acquisition of FDA-licensed smallpox vaccine’s business of Sanofi SNY – ACAM2000. The company paid an upfront payment of $97.5 million and $20 million in milestone payments. The deal also includes a potential milestone payment of up to $7.5 million, tied to the achievement of remaining regulatory
{iframe}http://www.nasdaq.com/article/emergent-biosolutions-acquires-sanofis-smallpox-vaccine-unit-cm857001{/iframe}